DAVITA INC. Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax
DAVITA INC. (DVA) reported Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax of $2.80 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Income Statement › Other Income
us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax · last filed 2026-08-04
- DAVITA INC. other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification, after tax for the quarter ending 2026-06-30 was $2.80M.
- DAVITA INC. other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification, after tax for the quarter ending 2026-03-31 was $5.15M.
- DAVITA INC. other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification, after tax for the quarter ending 2025-12-31 was -$1.96M, a 120.47% decline year-over-year.
- DAVITA INC. other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification, after tax for the quarter ending 2025-09-30 was -$4.42M.
- DAVITA INC. other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification, after tax for fiscal 2025 was -$21.32M, a 394.08% decline from fiscal 2024.
- DAVITA INC. other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification, after tax for fiscal 2024 was $7.25M, a 5.15% increase from fiscal 2023.
- DAVITA INC. other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification, after tax for fiscal 2023 was $6.89M, a 93.66% decline from fiscal 2022.
- DAVITA INC. other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification, after tax for fiscal 2022 was $108.67M, a 1418.78% increase from fiscal 2021.
| Period end | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax 3 month | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax 6 month | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax 9 month | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.80M 10-Q · filed 2026-08-04 | $7.95M 10-Q · filed 2026-08-04 | $5.99M derived: sum of 3 quarters · filed 2026-08-04 | $1.57M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $5.15M 10-Q · filed 2026-05-05 | $3.19M derived: sum of 2 quarters · filed 2026-05-05 | -$1.23M derived: sum of 3 quarters · filed 2026-05-05 | -$7.63M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | -$1.96M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | -$6.38M derived: sum of 2 quarters · filed 2026-02-11 | -$12.79M derived: sum of 3 quarters · filed 2026-08-04 | -$21.32M 10-K · filed 2026-02-11 |
| 2025-09-30 | -$4.42M 10-Q · filed 2025-10-29 | -$10.82M derived: sum of 2 quarters · filed 2026-08-04 | -$19.36M 10-Q · filed 2025-10-29 | -$9.77M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | -$6.41M 10-Q · filed 2026-08-04 | -$14.94M 10-Q · filed 2026-08-04 | -$5.35M derived: sum of 3 quarters · filed 2026-08-04 | -$26.93M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | -$8.54M 10-Q · filed 2026-05-05 | $1.05M derived: sum of 2 quarters · filed 2026-05-05 | -$20.52M derived: sum of 3 quarters · filed 2026-05-05 | -$14.60M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $9.59M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | -$11.99M derived: sum of 2 quarters · filed 2026-02-11 | -$6.07M derived: sum of 3 quarters · filed 2026-02-11 | $7.25M 10-K · filed 2026-02-11 |
| 2024-09-30 | -$21.58M 10-Q · filed 2025-10-29 | -$15.66M derived: sum of 2 quarters · filed 2025-10-29 | -$2.34M 10-Q · filed 2025-10-29 | -$23.75M derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-06-30 | $5.92M 10-Q · filed 2025-08-05 | $19.24M 10-Q · filed 2025-08-05 | -$2.17M derived: sum of 3 quarters · filed 2026-02-11 | $4.82M derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-03-31 | $13.32M 10-Q · filed 2025-05-12 | -$8.09M derived: sum of 2 quarters · filed 2026-02-11 | -$1.10M derived: sum of 3 quarters · filed 2026-02-11 | $23.75M derived: sum of 4 quarters · filed 2026-02-11 |
| 2023-12-31 | -$21.41M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | -$14.41M derived: sum of 2 quarters · filed 2026-02-11 | $10.44M derived: sum of 3 quarters · filed 2026-02-11 | $6.89M 10-K · filed 2026-02-11 |
| 2023-09-30 | $7.00M 10-Q · filed 2024-10-29 | $31.84M derived: sum of 2 quarters · filed 2024-10-29 | $28.30M 10-Q · filed 2024-10-29 | $41.31M derived: sum of 4 quarters · filed 2025-02-13 |
| 2023-06-30 | $24.85M 10-Q · filed 2024-08-06 | $21.31M 10-Q · filed 2024-08-06 | $34.32M derived: sum of 3 quarters · filed 2025-02-13 | $75.63M derived: sum of 4 quarters · filed 2025-02-13 |
| 2023-03-31 | -$3.54M 10-Q · filed 2024-05-02 | $9.47M derived: sum of 2 quarters · filed 2025-02-13 | $50.78M derived: sum of 3 quarters · filed 2025-02-13 | $64.00M derived: sum of 4 quarters · filed 2025-02-13 |
| 2022-12-31 | $13.01M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13 | $54.32M derived: sum of 2 quarters · filed 2025-02-13 | $67.54M derived: sum of 3 quarters · filed 2025-02-13 | $108.67M 10-K · filed 2025-02-13 |
| 2022-09-30 | $41.31M 10-Q · filed 2023-11-07 | $54.53M derived: sum of 2 quarters · filed 2023-11-07 | $95.66M 10-Q · filed 2023-11-07 | $100.35M derived: sum of 4 quarters · filed 2024-02-14 |
| 2022-06-30 | $13.22M 10-Q · filed 2023-08-03 | $54.35M 10-Q · filed 2023-08-03 | $59.04M derived: sum of 3 quarters · filed 2024-02-14 | $58.68M derived: sum of 4 quarters · filed 2024-02-14 |
| 2022-03-31 | $41.13M 10-Q · filed 2023-05-08 | $45.82M derived: sum of 2 quarters · filed 2024-02-14 | $45.46M derived: sum of 3 quarters · filed 2024-02-14 | $43.41M derived: sum of 4 quarters · filed 2024-02-14 |
| 2021-12-31 | $4.69M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14 | $4.33M derived: sum of 2 quarters · filed 2024-02-14 | $2.27M derived: sum of 3 quarters · filed 2024-02-14 | $7.16M 10-K · filed 2024-02-14 |
| 2021-09-30 | -$357.00K 10-Q · filed 2022-10-31 | -$2.42M derived: sum of 2 quarters · filed 2022-10-31 | $2.47M 10-Q · filed 2022-10-31 | $2.59M derived: sum of 4 quarters · filed 2023-02-22 |
| 2021-06-30 | -$2.06M 10-Q · filed 2022-08-01 | $2.82M 10-Q · filed 2022-08-01 | $2.95M derived: sum of 3 quarters · filed 2023-02-22 | $1.32M derived: sum of 4 quarters · filed 2023-02-22 |
| 2021-03-31 | $4.88M 10-Q · filed 2022-05-05 | $5.01M derived: sum of 2 quarters · filed 2023-02-22 | $3.38M derived: sum of 3 quarters · filed 2023-02-22 | |
| 2020-12-31 | $124.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | -$1.50M derived: sum of 2 quarters · filed 2023-02-22 | -$16.35M 10-K · filed 2023-02-22 | |
| 2020-09-30 | -$1.63M 10-Q · filed 2021-10-28 | -$16.47M 10-Q · filed 2021-10-28 | ||
| 2019-12-31 | $1.15M 10-K · filed 2022-02-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |